ENDRA Life Sciences Inc. (NDRA) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

ENDRA Life Sciences Inc. (NDRA) closed at USD 4.78 on 2026-10-14, a change of -9.5 % over the past year, with a market capitalization of USD 7.65M.

ENDRA Life Sciences Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

ENDRA Life Sciences Inc. key figures

Previous close

USD 4.78 (2026-10-14)

1-year change

-9.5 %

Market cap

USD 7.65M

Enterprise value

USD 6.34M

P/E ratio (trailing)

-0.87

P/E ratio (forward)

-1.68

EPS (trailing)

-5.87

EPS (forward)

-3.04

PEG ratio

n/a

Price to book

1.21

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.46

Employees

9

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for ENDRA Life Sciences Inc. and compare it with other stocks.